|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,600,109 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
47,137 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-07-01 |
4 |
D |
$5.35 |
$12,851 |
D/D |
(2,402) |
37,137 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-07-01 |
4 |
OE |
$4.44 |
$11,877 |
D/D |
2,675 |
39,539 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2010-06-22 |
4 |
S |
$5.81 |
$13,723 |
D/D |
(2,364) |
35,494 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-06-22 |
4 |
S |
$5.74 |
$13,818 |
D/D |
(2,409) |
36,625 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-06-22 |
4 |
S |
$5.82 |
$35,961 |
D/D |
(6,180) |
31,186 |
|
- |
|
Baker Mark Robert |
President |
|
2010-06-22 |
4 |
S |
$5.66 |
$13,186 |
D/D |
(2,328) |
26,689 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-06-18 |
4 |
AS |
$6.25 |
$25,000 |
D/D |
(4,000) |
32,925 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-06-01 |
4 |
AB |
$4.99 |
$24,950 |
D/D |
5,000 |
824,057 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-05-20 |
4 |
AB |
$4.89 |
$24,630 |
D/D |
5,000 |
819,057 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
44,723 |
849,665 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-04-01 |
4 |
D |
$5.36 |
$17,157 |
D/D |
(3,201) |
37,366 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-04-01 |
4 |
OE |
$4.56 |
$16,028 |
D/D |
3,518 |
40,567 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2010-04-01 |
4 |
D |
$5.36 |
$12,146 |
D/D |
(2,266) |
37,858 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2010-04-01 |
4 |
OE |
$4.56 |
$11,344 |
D/D |
2,490 |
40,124 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-04-01 |
4 |
D |
$5.36 |
$12,784 |
D/D |
(2,385) |
39,034 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-04-01 |
4 |
OE |
$4.56 |
$11,941 |
D/D |
2,621 |
41,419 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-03-18 |
4 |
AS |
$5.37 |
$37,891 |
D/D |
(7,056) |
36,842 |
|
- |
|
Baker Mark Robert |
President |
|
2010-03-18 |
4 |
AS |
$5.33 |
$11,539 |
D/D |
(2,165) |
28,423 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-01-04 |
4 |
D |
$4.45 |
$12,745 |
D/D |
(2,864) |
36,482 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-01-04 |
4 |
OE |
$3.78 |
$11,905 |
D/D |
3,147 |
39,346 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2010-01-04 |
4 |
D |
$4.45 |
$19,113 |
D/D |
(4,295) |
30,588 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2010-01-04 |
4 |
OE |
$3.78 |
$17,856 |
D/D |
4,720 |
34,883 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2010-01-04 |
4 |
D |
$4.45 |
$12,104 |
D/D |
(2,720) |
37,427 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2010-01-04 |
4 |
OE |
$3.78 |
$11,307 |
D/D |
2,989 |
40,147 |
|
- |
|
801 Records found
|
|
Page 8 of 33 |
|
|